Literature DB >> 18477038

The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia.

Jane S Hankins1, Gail L Fortner, M Beth McCarville, Matthew P Smeltzer, Winfred C Wang, Chin-Shang Li, Russell E Ware.   

Abstract

Children with sickle cell anaemia (SCA) and conditional transcranial Doppler (TCD) [time-averaged mean velocity (TAMV) 170-199 cm/s] have increased risk of primary stroke, but receive no specific therapy. Some will convert to abnormal velocities (TAMV >/=200 cm/s) with further increase in stroke risk. In 2003, our centre initiated universal TCD screening, targeting all children (aged 2-16 years) with SCA. TCD examinations were repeated at intervals based on initial results. To determine rates and risk factors for TCD conversion, we reviewed all examinations since 2003, excluding patients receiving hydroxycarbamide (hydroxyurea) or transfusions. Of the eligible population, 274 children (98%) were screened at a median age of 7.1 years (range 1.7-18.2). Fifty-four patients (20%) had conditional TAMV either on initial screening or a subsequent examination. The 18-month cumulative incidence of conversion from conditional to abnormal TAMV was 23%. Age, initial TAMV, laboratory values, blood pressure and oxygen saturation were not significantly associated with conversion. Our cohort provides systematic longitudinal evaluation of an unselected paediatric population universally screened and retested at regular intervals. Our data document a high conversion rate to abnormal velocities among untreated children with SCA. Therapy should be considered for the prevention of conversion to abnormal TCD velocities.

Entities:  

Mesh:

Year:  2008        PMID: 18477038     DOI: 10.1111/j.1365-2141.2008.07167.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  Sickle cell disease: reference values and interhemispheric differences of nonimaging transcranial Doppler blood flow parameters.

Authors:  M Arkuszewski; J Krejza; R Chen; J L Kwiatkowski; R Ichord; R Zimmerman; K Ohene-Frempong; L Desiderio; E R Melhem
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-23       Impact factor: 3.825

2.  Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium.

Authors:  Alyssa M Schlenz; Shannon Phillips; Martina Mueller; Cathy Melvin; Robert J Adams; Julie Kanter
Journal:  Pediatr Blood Cancer       Date:  2020-01-11       Impact factor: 3.167

3.  Sickle cell disease and transcranial Doppler imaging: inter-hemispheric differences in blood flow Doppler parameters.

Authors:  Jaroslaw Krejza; Rong Chen; Grzegorz Romanowicz; Janet L Kwiatkowski; Rebecca Ichord; Michal Arkuszewski; Robert Zimmerman; Kwaku Ohene-Frempong; Lisa Desiderio; Elias R Melhem
Journal:  Stroke       Date:  2010-11-18       Impact factor: 7.914

4.  Clinical events after surgical splenectomy in children with sickle cell anemia.

Authors:  Ram Kalpatthi; Ian D Kane; Ibrahim F Shatat; Betsy Rackoff; Deborah Disco; Sherron M Jackson
Journal:  Pediatr Surg Int       Date:  2010-03-23       Impact factor: 1.827

Review 5.  Sickle cell disease in children.

Authors:  Emily Riehm Meier; Jeffery L Miller
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

Review 6.  Transcranial Doppler in children.

Authors:  Suzanne Verlhac
Journal:  Pediatr Radiol       Date:  2011-04-27

7.  Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia.

Authors:  Jonathan M Flanagan; Vivien Sheehan; Heidi Linder; Thad A Howard; Yong-Dong Wang; Carolyn C Hoppe; Banu Aygun; Robert J Adams; Geoffrey A Neale; Russell E Ware
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

8.  Original Research: Sickle cell anemia and pediatric strokes: Computational fluid dynamics analysis in the middle cerebral artery.

Authors:  Christian P Rivera; Alessandro Veneziani; Russell E Ware; Manu O Platt
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-04

9.  Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial.

Authors:  Jane S Hankins; Mary Beth McCarville; Angela Rankine-Mullings; Marvin E Reid; Clarisse L C Lobo; Patricia G Moura; Susanna Ali; Deanne P Soares; Karen Aldred; Dennis W Jay; Banu Aygun; John Bennett; Guolian Kang; Jonathan C Goldsmith; Matthew P Smeltzer; James M Boyett; Russell E Ware
Journal:  Am J Hematol       Date:  2015-11-17       Impact factor: 10.047

10.  A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia.

Authors:  Courtney D Thornburg; Natalia Dixon; Shelly Burgett; Nicole A Mortier; William H Schultz; Sherri A Zimmerman; Melanie Bonner; Kristina K Hardy; Agustin Calatroni; Russell E Ware
Journal:  Pediatr Blood Cancer       Date:  2009-05       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.